ENTITY
Lupin

Lupin (LPC IN)

279
Analysis
Health Care • India
Lupin is an Indian multinational pharmaceutical company that develops, manufactures, and markets a diverse range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company specializes in therapeutic areas such as cardiovascular, anti-diabetic, respiratory, anti-infective, and women's health. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
more
•04 Apr 2025 05:21•Broker

Trump Tariffs - Possible Impact on Our Market

President Donald Trump and the White House revealed a list of U.S. “reciprocal tariff” rates that more than 180 countries and territories are set...

Logo
216 Views
Share
•02 Apr 2025 04:32•Broker

Axis Top Picks for the month of April 2025

The Axis Top Picks Basket delivered an excellent return of 8.9% in Mar’25 against the 6.3% return posted by the Nifty 50, thereby beating the...

Logo
300 Views
Share
•04 Mar 2025 00:57•Broker

Axis Top Picks for the month of March 2025

Axis Top pick basket declined by 9% in Feb’25 in a highly volatile month that witnessed rather mixed performance across the sector, market cap and...

Logo
416 Views
Share
•19 Feb 2025 21:14•Broker

Top Conviction Ideas - “Pharmaceutical & Hospitals”

The pharmaceutical universe under our coverage reported Q3FY25 growth of 10.2% YoY and 2.3% QoQ, driven by strong growth in the India business...

Logo
411 Views
Share
•14 Feb 2025 02:44•Broker

HSIE Results Daily: Siemens, Lupin, Ashok Leyland, Bharat Forge, Steel Authority of India

Siemens: Siemens India Ltd (SIL) delivered standalone (including energy business) Q1FY25 revenue/EBITDA/APAT of INR 45/5.6/4.9bn, a miss/beat to...

Logo
327 Views
Share
x